Advertisement
Original Study| Volume 21, ISSUE 10, P1481-1489.e3, October 2020

Download started.

Ok

Cumulative and Incremental Value of Sarcopenia Components on Predicting Adverse Outcomes

  • Freddy M.H. Lam
    Affiliations
    Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong

    Jockey Club Centre for Osteoporosis Care and Control, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
    Search for articles by this author
  • Yi Su
    Affiliations
    Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
    Search for articles by this author
  • Zhi-Hui Lu
    Affiliations
    Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong
    Search for articles by this author
  • Ruby Yu
    Affiliations
    Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong

    Jockey Club Institute of Ageing, The Chinese University of Hong Kong, Hong Kong
    Search for articles by this author
  • Jason C.S. Leung
    Affiliations
    Jockey Club Centre for Osteoporosis Care and Control, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
    Search for articles by this author
  • Timothy C.Y. Kwok
    Correspondence
    Address correspondence to Timothy C. Y. Kwok, MD, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.
    Affiliations
    Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong

    Jockey Club Centre for Osteoporosis Care and Control, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
    Search for articles by this author
Published:August 05, 2020DOI:https://doi.org/10.1016/j.jamda.2020.05.056

      Abstract

      Objectives

      To examine the incremental value of sarcopenia components, following the diagnosis algorithm of the Asian consensus, on predicting adverse outcomes.

      Design

      A prospective cohort study.

      Setting and Participants

      Four thousand community-dwelling Chinese adults (2000 men) aged 65 years or older in Hong Kong (mean age = 72.5 ± 5.2).

      Methods

      SARC-F was used as the initial predictor of 9 adverse outcomes. In step 2, muscle strength (ie, grip strength) and/or functions (ie, chair-stand, walking speed) were added on top of SARC-F. In step 3, height-, weight-, and body mass index–adjusted appendicular skeletal mass (ASM) measured by dual-energy x-ray absorptiometry (DXA) were added separately to all models formulated in step 2. The areas under the receiver operating characteristic curve (AUCs) were calculated for the models formulated in all steps. Each cumulative AUC would be compared with the AUC yielded in the previous step to evaluate the incremental prediction value.

      Results

      On top of SARC-F, assessing grip strength, walking speed, or 5-time chair-stand significantly increased the AUC for most adverse outcomes. In particular, assessing both grip strength and gait speed yielded the highest AUC in most prediction models (AUC = 0.539-0.770) and significantly increased the AUC for all outcomes except for recurrent falls. With both muscle strength and function assessed, adding ASM failed to significantly increase the AUC except for 2 conditions. In the 2 conditions, however, a higher height-adjusted ASM was associated with a higher risk of having worsened physical limitations [OR 1.25, 95% confidence interval (CI) 1.12-1.40] and decline in the physical quality of life (OR 1.18, 95% CI 1.06-1.33) in women.

      Conclusions and Implications

      Assessing muscle strength and function provides additional power to predict adverse outcomes on top of SARC-F. Further assessment of muscle mass with DXA provides no extra constructive value ito bettering the prediction regardless of the adjustment parameters. Alternative technologies to measure muscle mass might be required.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Anker S.D.
        • Morley J.E.
        • von Haehling S.
        Welcome to the ICD-10 code for sarcopenia.
        J Cachexia Sarcopenia Muscle. 2016; 7: 512-514
        • Chen L.K.
        • Liu L.K.
        • Woo J.
        • et al.
        Sarcopenia in Asia: Consensus report of the Asian working group for sarcopenia.
        J Am Med Dir Assoc. 2014; 15: 95-101
        • Cruz-Jentoft A.J.
        • Bahat G.
        • Bauer J.
        • et al.
        Sarcopenia: Revised European consensus on definition and diagnosis.
        Age Ageing. 2019; 48: 16-31
        • Fielding R.A.
        • Vellas B.
        • Evans W.J.
        • et al.
        Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia.
        J Am Med Dir Assoc. 2011; 12: 249-256
        • Studenski S.A.
        • Peters K.W.
        • Alley D.E.
        • et al.
        The FNIH sarcopenia project: Rationale, study description, conference recommendations, and final estimates.
        J Gerontol A Biol Sci Med Sci. 2014; 69: 547-558
        • Dent E.
        • Morley J.E.
        • Cruz-Jentoft A.J.
        • et al.
        International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, diagnosis and management.
        J Nutr Heal Aging. 2018; 22: 1148-1161
        • Chen L.K.
        • Woo J.
        • Assantachai P.
        • et al.
        Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment.
        J Am Med Dir Assoc. 2020; 21: 300-307.e2
        • Bauer J.
        • Morley J.E.
        • Schols A.M.W.J.
        • et al.
        Sarcopenia: A time for action. An SCWD position paper.
        J Cachexia Sarcopenia Muscle. 2019; 10: 956-961
        • Schaap L.A.
        • Van Schoor N.M.
        • Lips P.
        • Visser M.
        Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: The longitudinal aging study Amsterdam.
        J Gerontol A Biol Sci Med Sci. 2018; 73: 1199-1204
        • Landi F.
        • Liperoti R.
        • Russo A.
        • et al.
        Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study.
        Clin Nutr. 2012; 31: 652-658
        • Woo J.
        • Leung J.
        • Morley J.E.
        Defining sarcopenia in terms of incident adverse outcomes.
        J Am Med Dir Assoc. 2015; 16: 247-252
        • Bahat G.
        • Ilhan B.
        Sarcopenia and the cardiometabolic syndrome: A narrative review.
        Eur Geriatr Med. 2016; 7: 220-223
        • Chang K.V.
        • Hsu T.H.
        • Wu W.T.
        • et al.
        Association between sarcopenia and cognitive impairment: A systematic review and meta-analysis.
        J Am Med Dir Assoc. 2016; 17 (1164.e7-1164.e15)
        • Beaudart C.
        • Biver E.
        • Reginster J.Y.
        • et al.
        Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia.
        J Cachexia Sarcopenia Muscle. 2017; 8: 238-244
        • Kim J.H.
        • Lim S.
        • Choi S.H.
        • et al.
        Sarcopenia: An independent predictor of mortality in community-dwelling older Korean men.
        J Gerontol A Biol Sci Med Sci. 2014; 69: 1244-1252
        • Landi F.
        • Liperoti R.
        • Fusco D.
        • et al.
        Sarcopenia and mortality among older nursing home residents.
        J Am Med Dir Assoc. 2012; 13: 121-126
        • Vetrano D.L.
        • Landi F.
        • Volpato S.
        • et al.
        Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: Results from the CRIME study.
        J Gerontol A Biol Sci Med Sci. 2014; 69: 1154-1161
        • Leong D.P.
        • Teo K.K.
        • Rangarajan S.
        • et al.
        Prognostic value of grip strength: Findings from the Prospective Urban Rural Epidemiology (PURE) study.
        Lancet. 2015; 386: 266-273
        • Alley D.E.
        • Shardell M.D.
        • Peters K.W.
        • et al.
        Grip strength cutpoints for the identification of clinically relevant weakness.
        J Gerontol A Biol Sci Med Sci. 2014; 69: 559-566
        • Schaap L.A.
        • Koster A.
        • Visser M.
        Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons.
        Epidemiol Rev. 2013; 35: 51-65
        • Balogun S.
        • Winzenberg T.
        • Wills K.
        • et al.
        Prospective associations of low muscle mass and function with 10-year falls risk, incident fracture and mortality in community-dwelling older adults.
        J Nutr Health Aging. 2017; 21: 843-848
        • McLean R.R.
        • Kiel D.P.
        • Berry S.D.
        • et al.
        Lower lean mass measured by dual-energy x-ray absorptiometry (DXA) is not associated with increased risk of hip fracture in women: The Framingham Osteoporosis Study.
        Calcif Tissue Int. 2018; 103: 16-23
        • Woo J.
        • Leung J.
        Anthropometric cut points for definition of Sarcopenia based on incident mobility and physical limitation in older Chinese people.
        J Gerontol A Biol Sci Med Sci. 2016; 71: 935-940
        • dos Santos L.
        • Cyrino E.S.
        • Antunes M.
        • et al.
        Sarcopenia and physical independence in older adults: The independent and synergic role of muscle mass and muscle function.
        J Cachexia Sarcopenia Muscle. 2017; 8: 245-250
        • Kwok A.W.L.
        • Gong J.S.
        • Wang Y.X.J.
        • et al.
        Prevalence and risk factors of radiographic vertebral fractures in elderly Chinese men and women: Results of Mr. OS (Hong Kong) and Ms. OS (Hong Kong) studies.
        Osteoporos Int. 2013; 24: 877-885
        • Woo J.
        • Leung J.
        • Morley J.E.
        Validating the SARC-F: A suitable community screening tool for sarcopenia?.
        J Am Med Dir Assoc. 2014; 15: 630-634
        • Heymsfield S.B.
        • Smith R.
        • Aulet M.
        • et al.
        Appendicular skeletal muscle mass: Measurement by dual-photon absorptiometry.
        Am J Clin Nutr. 1990; 52: 214-218
        • Ware J.
        • Kosinski M.
        • Keller S.
        SF-12: How to Score the SF-12 Physical and Mental Health Summary Scales.
        4th ed. QualityMetric Inc, Lincoln, RI2002
        • Jayadevappa R.
        • Cook R.
        • Chhatre S.
        Minimal important difference to infer changes in health-related quality of life—a systematic review.
        J Clin Epidemiol. 2017; 89: 188-198
        • Woo J.
        • Leung J.
        • Sham A.
        • Kwok T.
        Defining sarcopenia in terms of risk of physical limitations: A 5-year follow-up study of 3,153 Chinese men and women.
        J Am Geriatr Soc. 2009; 57: 2224-2231
        • Tessier A.
        • Wing S.S.
        • Rahme E.
        • et al.
        Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.
        J Cachexia Sarcopenia Muscle. 2019; 10: 985-999
        • Woo J.
        • Leung J.
        • Kwok T.
        BMI, body composition, and physical functioning in older adults.
        Obesity. 2007; 15: 1886-1894
        • Janssen I.
        • Heymsfield S.B.
        • Ross R.
        Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.
        J Am Geriatr Soc. 2002; 50: 889-896
        • Estrada M.
        • Kleppinger A.
        • Judge J.O.
        • et al.
        Functional impact of relative versus absolute sarcopenia in healthy older women.
        J Am Geriatr Soc. 2007; 55: 1712-1719
        • Su Y.
        • Leung J.
        • Hans D.
        • et al.
        Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: The Mr. OS and Ms. OS cohort study in Hong Kong.
        Osteoporos Int. 2017; 28: 151-160
        • Cawthon P.M.
        • Orwoll E.S.
        • Peters K.E.
        • et al.
        Strong relation between muscle mass determined by D3-creatine dilution, physical performance, and incidence of falls and mobility limitations in a prospective cohort of older men.
        J Gerontol A Biol Sci Med Sci. 2019; 74: 844-852
        • Kim J.
        • Heshka S.
        • Gallagher D.
        • et al.
        Intermuscular adipose tissue-free skeletal muscle mass: Estimation by dual-energy x-ray absorptiometry in adults.
        J Appl Physiol. 2004; 97: 655-660